{"@context":{"dc":"http:\/\/purl.org\/dc\/elements\/1.1\/","skos":"http:\/\/www.w3.org\/2004\/02\/skos\/core#","skos:broader":{"@type":"@id"},"skos:inScheme":{"@type":"@id"},"skos:related":{"@type":"@id"},"skos:narrower":{"@type":"@id"},"skos:hasTopConcept":{"@type":"@id"},"skos:topConceptOf":{"@type":"@id"}},"@id":"https:\/\/adm.senado.leg.br\/vcb\/vocab\/skos\/3707","@type":"skos:Concept","skos:prefLabel":{"@language":"pt-BR","@value=":"Neoplasia"},"skos:inScheme":"https:\/\/adm.senado.leg.br\/vcb\/vocab\/","dct:created":"2020-09-18 17:43:08","skos:definition":[{"@lang":"ab","@value":"Crescimento novo anormal de tecido. As neoplasias malignas apresentam um maior grau de anaplasia e t\u00eam propriedades de invas\u00e3o e de met\u00e1stase quando comparadas \u00e0s neoplasias benignas.$vDeCS "}],"skos:narrower":["https:\/\/adm.senado.leg.br\/vcb\/vocab\/skos\/6007","https:\/\/adm.senado.leg.br\/vcb\/vocab\/skos\/6008","https:\/\/adm.senado.leg.br\/vcb\/vocab\/skos\/6009","https:\/\/adm.senado.leg.br\/vcb\/vocab\/skos\/6010"],"skos:broader":["https:\/\/adm.senado.leg.br\/vcb\/vocab\/skos\/1936"],"skos:altLabel":[{"language":"pt-BR","value":"C\u00e2ncer"},{"language":"pt-BR","value":"Cancro (tumor maligno)"},{"language":"pt-BR","value":"Neoplasia benigna"},{"language":"pt-BR","value":"Neoplasia maligna"},{"language":"pt-BR","value":"Neoplasma"},{"language":"pt-BR","value":"Tumor"}],"skos:related":["https:\/\/adm.senado.leg.br\/vcb\/vocab\/skos\/5407","https:\/\/adm.senado.leg.br\/vcb\/vocab\/skos\/6002","https:\/\/adm.senado.leg.br\/vcb\/vocab\/skos\/6003","https:\/\/adm.senado.leg.br\/vcb\/vocab\/skos\/6004","https:\/\/adm.senado.leg.br\/vcb\/vocab\/skos\/6005","https:\/\/adm.senado.leg.br\/vcb\/vocab\/skos\/6006","https:\/\/adm.senado.leg.br\/vcb\/vocab\/skos\/20586"]}